{
  "main_header": {
    "sid": 1002834,
    "name": "Lasa Supergeneri",
    "stock_name": "Lasa Supergeneri",
    "full_name": "Lasa Supergenerics Ltd",
    "name_url": "stocks-analysis/lasa-supergeneri",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "18.09",
    "chg": 0.29,
    "chgp": "1.63%",
    "dir": 1,
    "prev_price": "17.80",
    "mcapval": "90.63 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540702,
    "symbol": "LASA",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE670X01014",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "23:52 PM",
    "bse_nse_vol": "27.75 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lasa-supergeneri-1002834-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Lasa Supergenerics Faces Financial Challenges Amid Broader Market Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-hits-new-52-week-low-amid-ongoing-decline-in-profitability-1623662",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/LasaSupergeneri_priceRelatedfactors_818442.png",
        "date": "2025-03-27 10:07:31",
        "description": "Lasa Supergenerics, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid ongoing volatility, losing nearly 10% in four days. The company's financial health is concerning, with significant declines in operating profits and profit after tax, contrasting with broader market resilience."
      },
      {
        "title": "Lasa Supergenerics Faces Ongoing Challenges Amidst Significant Stock Volatility and Poor Financial Health",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-hits-52-week-low-amid-ongoing-stock-decline-and-poor-financial-metrics-1623667",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/LasaSupergeneri_priceRelatedfactors_818439.png",
        "date": "2025-03-27 10:07:31",
        "description": "Lasa Supergenerics, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low, marking four consecutive days of losses. The company has struggled over the past year, with significant declines in operating profits and a notable drop in quarterly profits, raising concerns about its financial health."
      },
      {
        "title": "Lasa Supergenerics Faces Financial Struggles Amid Broader Market Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-hits-52-week-low-amid-ongoing-decline-and-poor-financial-performance-1623673",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/LasaSupergeneri_priceRelatedfactors_818435.png",
        "date": "2025-03-27 10:07:30",
        "description": "Lasa Supergenerics, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid significant volatility. The company's financial performance raises concerns, with negative growth in operating profits and low return on equity, while the broader market shows resilience."
      },
      {
        "title": "Lasa Supergenerics Faces Financial Struggles Amid Broader Market Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-hits-52-week-low-amid-ongoing-financial-challenges-and-declining-stock-performance-1623671",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/LasaSupergeneri_priceRelatedfactors_818437.png",
        "date": "2025-03-27 10:07:29",
        "description": "Lasa Supergenerics has faced notable volatility, reaching a new 52-week low and marking four consecutive days of losses. The company's financial performance has been concerning, with significant declines in operating profits and a negative EBIT to interest ratio, raising questions about its long-term viability amidst broader market resilience."
      },
      {
        "title": "Lasa Supergenerics Faces Continued Challenges Amidst Significant Stock Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-hits-new-52-week-low-amid-ongoing-decline-and-poor-financial-performance-1600429",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/LasaSupergeneri_priceRelatedfactors_796765.png",
        "date": "2025-03-26 09:46:54",
        "description": "Lasa Supergenerics, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low, continuing a downward trend. The company has struggled over the past year, with negative returns and weak fundamentals, including a significant decline in operating profits and concerning debt servicing capabilities."
      },
      {
        "title": "Lasa Supergenerics Faces Ongoing Challenges Amid Significant Stock Volatility and Poor Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-hits-new-52-week-low-amid-ongoing-stock-decline-1600425",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/LasaSupergeneri_priceRelatedfactors_796767.png",
        "date": "2025-03-26 09:46:52",
        "description": "Lasa Supergenerics, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low, continuing a downward trend. The company has struggled financially, with a significant decline in operating profits and a poor EBIT to interest ratio, reflecting ongoing challenges and underperformance against market benchmarks."
      },
      {
        "title": "Lasa Supergenerics Faces Ongoing Challenges Amidst Significant Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-hits-52-week-low-amid-significant-stock-decline-and-poor-performance-1600427",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/LasaSupergeneri_priceRelatedfactors_796766.png",
        "date": "2025-03-26 09:46:52",
        "description": "Lasa Supergenerics has faced notable volatility, reaching a new 52-week low amid a downward trend. The company has struggled with negative growth in operating profits and a concerning EBIT to Interest ratio. Recent quarterly results indicate a significant decline in profit after tax, reflecting ongoing challenges in the market."
      },
      {
        "title": "Lasa Supergenerics Faces Ongoing Market Challenges Amid Significant Stock Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-hits-new-52-week-low-amid-significant-profit-decline-1587584",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/LasaSupergeneri_priceRelatedfactors_793368.png",
        "date": "2025-03-25 15:37:43",
        "description": "Lasa Supergenerics has hit a new 52-week low, reflecting significant volatility and underperformance in the Pharmaceuticals & Drugs sector. The company faces ongoing challenges, including declining operating profits, a low return on equity, and struggles with debt servicing, contributing to its negative market position."
      },
      {
        "title": "Lasa Supergenerics Faces Continued Volatility Amid Broader Market Decline and Profitability Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-hits-52-week-low-amid-significant-stock-decline-and-weak-fundamentals-1180377",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/LasaSupergeneri_priceRelatedfactors_565854.png",
        "date": "2025-03-04 10:33:02",
        "description": "Lasa Supergenerics has reached a new 52-week low, continuing a downward trend with significant volatility. The company faces challenges in financial performance, including negative operating profit growth and low return on equity. Meanwhile, the broader market shows mixed signals, with small-cap stocks demonstrating some resilience."
      }
    ],
    "total": 21,
    "sid": "1002834",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/lasa-supergenerics-1002834"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2025",
      "details": "This is to inform you that as per the Company Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders in terms of (Prohibiton of Insider Trading) Regulations 2015 as amended the trading window for dealing in the equity shares of the Company shall be closed for designated employees and their immediate relatives w.e.f April 01 2025 till 48 hours after the declaration of Audited Financial Results for the quarter and the year ended March 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Integrated Filing (Financial)",
      "datetime": "04-Mar-2025",
      "details": "Pursuant to SEBI Circular No. SEBI /HO/CFD/CFD-PoD-2 /CIR/P/2024/185 Dated 31.12.2024 read with BSE circular and NSE circluar dated 02.01.2025. We are submitting herewith the Integrated filing (Financial) for the quarter ended December 31 2024",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of EGM",
      "datetime": "22-Feb-2025",
      "details": "Pursuant of Reg 30 of SEBI LODR Regulations 2015 as amended we are submitting herewith the summary of proceedings of EOGM held pn Saturday February 22 2025 at 9.30 A.M. and Concluded at 9.53 A.M through Video conferencing/other audio visual means. (VC/OAVM).",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lasa Supergenerics Ltd has declared <strong>2%</strong> dividend, ex-date: 16 Sep 22",
          "dt": "2022-09-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lasa Supergenerics Faces Financial Challenges Amid Broader Market Resilience

2025-03-27 10:07:31

Lasa Supergenerics, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid ongoing volatility, losing nearly 10% in four days. The company's financial health is concerning, with significant declines in operating profits and profit after tax, contrasting with broader market resilience.

Read More

Lasa Supergenerics Faces Ongoing Challenges Amidst Significant Stock Volatility and Poor Financial Health

2025-03-27 10:07:31

Lasa Supergenerics, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low, marking four consecutive days of losses. The company has struggled over the past year, with significant declines in operating profits and a notable drop in quarterly profits, raising concerns about its financial health.

Read More

Lasa Supergenerics Faces Financial Struggles Amid Broader Market Resilience

2025-03-27 10:07:30

Lasa Supergenerics, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid significant volatility. The company's financial performance raises concerns, with negative growth in operating profits and low return on equity, while the broader market shows resilience.

Read More

Lasa Supergenerics Faces Financial Struggles Amid Broader Market Resilience

2025-03-27 10:07:29

Lasa Supergenerics has faced notable volatility, reaching a new 52-week low and marking four consecutive days of losses. The company's financial performance has been concerning, with significant declines in operating profits and a negative EBIT to interest ratio, raising questions about its long-term viability amidst broader market resilience.

Read More

Lasa Supergenerics Faces Continued Challenges Amidst Significant Stock Volatility

2025-03-26 09:46:54

Lasa Supergenerics, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low, continuing a downward trend. The company has struggled over the past year, with negative returns and weak fundamentals, including a significant decline in operating profits and concerning debt servicing capabilities.

Read More

Lasa Supergenerics Faces Ongoing Challenges Amid Significant Stock Volatility and Poor Fundamentals

2025-03-26 09:46:52

Lasa Supergenerics, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low, continuing a downward trend. The company has struggled financially, with a significant decline in operating profits and a poor EBIT to interest ratio, reflecting ongoing challenges and underperformance against market benchmarks.

Read More

Lasa Supergenerics Faces Ongoing Challenges Amidst Significant Market Volatility

2025-03-26 09:46:52

Lasa Supergenerics has faced notable volatility, reaching a new 52-week low amid a downward trend. The company has struggled with negative growth in operating profits and a concerning EBIT to Interest ratio. Recent quarterly results indicate a significant decline in profit after tax, reflecting ongoing challenges in the market.

Read More

Lasa Supergenerics Faces Ongoing Market Challenges Amid Significant Stock Volatility

2025-03-25 15:37:43

Lasa Supergenerics has hit a new 52-week low, reflecting significant volatility and underperformance in the Pharmaceuticals & Drugs sector. The company faces ongoing challenges, including declining operating profits, a low return on equity, and struggles with debt servicing, contributing to its negative market position.

Read More

Lasa Supergenerics Faces Continued Volatility Amid Broader Market Decline and Profitability Concerns

2025-03-04 10:33:02

Lasa Supergenerics has reached a new 52-week low, continuing a downward trend with significant volatility. The company faces challenges in financial performance, including negative operating profit growth and low return on equity. Meanwhile, the broader market shows mixed signals, with small-cap stocks demonstrating some resilience.

Read More

View All News